12 Month Price Forecast For HJLI
Distance to HJLI Price Forecasts
HJLI Price Momentum
๐ค Considering Hancock Jaffe (HJLI)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 11, 2025 3:31 AM UTC
HJLI Analyst Ratings & Price Targets
Currently, there are no Wall Street analyst price targets or forecasts available for HJLI (Hancock Jaffe).
HJLI is currently trading at $3.05. Without active analyst coverage, investors should conduct thorough independent research and consider multiple data points beyond price targets when evaluating this stock for their portfolio.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HJLI Analyst Consensus
HJLI Price Target Range
Latest HJLI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HJLI.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
Stocks Similar to Hancock Jaffe Laboratories Inc
The following stocks are similar to Hancock Jaffe based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Hancock Jaffe Laboratories Inc (HJLI) Financial Data
Hancock Jaffe Laboratories Inc has a market capitalization of $29.58M with a P/E ratio of -0.4x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of N/A and return on equity of +14.9%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Hancock Jaffe Laboratories Inc (HJLI) Company Overview
About Hancock Jaffe Laboratories Inc
Company Information
Hancock Jaffe Laboratories Inc (HJLI) Latest News & Analysis
Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann
3 years agoHancock Jaffe Laboratories CEO Robert Berman will participate in a webinar on September 27, 2021, at 1:00 PM ET, hosted by Ladenburg Thalmann.
The webinar with Hancock Jaffe's CEO may provide insights into the company's strategy and performance, influencing investor sentiment and stock price.
Hancock Jaffe To Rebrand As enVVeno Medical
3 years agoHancock Jaffe Laboratories Inc (NASDAQ: HJLI) will rebrand as enVVeno Medical Corporation (ticker: NVNO) on October 1, focusing exclusively on its VenoValve for treating venous disease.
The rebranding and strategic focus on the VenoValve signal a commitment to a core product, potentially enhancing investor confidence and future growth prospects for enVVeno Medical.
Hancock Jaffe is rebranding as enVVeno Medical Corporation (NASDAQ: NVNO) effective October 1, 2021, focusing on venous disease and unveiling a new product in mid-2022.
Rebranding to enVVeno Medical and focusing on venous disease could signal a strategic shift, potentially enhancing growth prospects and attracting investor interest in innovative medical solutions.
Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021
3 years agoHancock Jaffe Laboratories, Inc. will hold a corporate update conference call and live video webcast on September 21, 2021, at 4:30 p.m. ET.
The upcoming conference call may reveal key updates on Hancock Jaffe's product development and financial performance, impacting investor sentiment and stock price.
Hancock Jaffe Laboratories (NASDAQ: HJLI) has secured a $20 million investment from Perceptive Advisors through a registered direct offering of 2,540,650 shares at $7.8720 each.
Hancock Jaffe's $20 million equity offering enhances its financial stability, enabling further development of its medical devices, which could drive future growth and investor returns.
Hancock Jaffe Laboratories, focused on bioprosthetics for cardiovascular diseases, received IDE approval in April 2021 for a pivotal trial of its VenoValve in the U.S.
Hancock Jaffe's IDE approval for the VenoValve trial indicates potential advancements in cardiovascular treatment, which could drive revenue growth and increase stock value.
Frequently Asked Questions About HJLI Stock
What is Hancock Jaffe Laboratories Inc's (HJLI) stock forecast for 2025?
Analyst forecasts for Hancock Jaffe Laboratories Inc (HJLI) are not currently available. The stock is trading at $3.05.
Is HJLI stock a good investment in 2025?
Analyst ratings for HJLI are not currently available. The stock is currently trading at $3.05. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for HJLI stock?
Price predictions from Wall Street analysts for HJLI are not currently available. The stock is trading at $3.05.
What is Hancock Jaffe Laboratories Inc's business model?
N/A
What is the highest forecasted price for HJLI Hancock Jaffe Laboratories Inc?
Price targets from Wall Street analysts for HJLI are not currently available. The stock is trading at $3.05.
What is the lowest forecasted price for HJLI Hancock Jaffe Laboratories Inc?
Price targets from Wall Street analysts for HJLI are not currently available. The stock is trading at $3.05.
What is the overall HJLI consensus from analysts for Hancock Jaffe Laboratories Inc?
Analyst ratings for HJLI are not currently available. The stock is trading at $3.05.
How accurate are HJLI stock price projections?
Stock price projections, including those for Hancock Jaffe Laboratories Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.